Prognostic Factors in MELAS Patients
Author Information
Author(s): Gao Rui, Gu Lihua, Zuo Wenchao, Wang Pan
Primary Institution: Department of Neurology, Tianjin Huanhu Hospital, Nankai University, Tianjin, China
Hypothesis
This study aimed to explore the relationship between clinical and biochemical markers and prognosis of patients with MELAS.
Conclusion
The study found that severe lactate levels and anemia are indicators of poor prognosis in MELAS patients.
Supporting Evidence
- 8 out of 39 patients died during the study, primarily due to acute stroke-like episodes.
- Patients with severe lactate elevation had a higher risk of mortality compared to those with normal levels.
- Anemia was associated with a lower risk of death compared to those with anemia.
Takeaway
This study looked at patients with a condition called MELAS and found that high levels of a substance called lactate and having anemia can make it more likely for patients to have worse health outcomes.
Methodology
This was a retrospective single-center study that followed 39 MELAS patients for an average of 7.3 years, collecting clinical and biochemical data.
Potential Biases
Potential selection bias as younger patients may have sought treatment at pediatric hospitals.
Limitations
The study is retrospective and may be subject to recall and selection bias.
Participant Demographics
Approximately 64% of patients were male, with a mean age at onset of 33.5 years.
Statistical Information
P-Value
0.040
Confidence Interval
95% CI 1.086–30.071
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website